ESC 365 - Who is at risk of cardiovascular toxicity? - discussion

Delegates Premium Access

Who is at risk of cardiovascular toxicity? - discussion

Session: Guidelines in Practice: who is at risk of cardiovascular toxicity?

Topic: Cardiovascular Toxicity Stratification

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

3 more presentations in this session

Risk stratification strategies in non-Hodgkin lymphoma: case presentation

Speaker: Professor J. Alexandre (Caen, FR)

Risk stratification strategies in patients receiving tyrosine kinase inhibitors: case presentation

Speaker: Doctor M. Mirabel (Paris, FR)

What do the ESC Guidelines on Cardio-Oncology say and how should they be implemented?

Speaker: Professor J. Liu (New York, US)

Access the full session

Guidelines in Practice: who is at risk of cardiovascular toxicity?

Speakers: Professor J. Alexandre, Doctor M. Mirabel, Professor J. Liu

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources